Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-20
2007-02-20
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S310700
Reexamination Certificate
active
10543177
ABSTRACT:
Novel compounds having hydroxybenzoimidazole carboxylic amide are useful for inhibiting glycogen synthase kinase 3β(GSK-3β).
REFERENCES:
patent: 5821258 (1998-10-01), Matsunaga et al.
patent: 6310082 (2001-10-01), Griffin et al.
patent: 6509365 (2003-01-01), Lubisch et al.
patent: WO 95/07263 (1995-03-01), None
patent: WO-00/29384 (2000-05-01), None
patent: WO 02/102978 (2002-12-01), None
Cho Joong Myung
Hyun Young-Lan
Jeon Young Ho
Kim Jin Hwan
Lee Kyung Joo
Crystalgenomics, Inc.
Stockton Laura L.
Sughrue & Mion, PLLC
Yuyu Inc.
LandOfFree
Glycogen synthase kinase 3β inhibitor, composition and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycogen synthase kinase 3β inhibitor, composition and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycogen synthase kinase 3β inhibitor, composition and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3845216